JPMorgan Chase & Co. Cuts Clorox (NYSE:CLX) Price Target to $92.00

Clorox (NYSE:CLX) had its price objective trimmed by JPMorgan Chase & Co. from $95.00 to $92.00 in a research report report published on Thursday morning,Benzinga reports. The firm currently has an underweight rating on the stock.

Several other research firms also recently issued reports on CLX. Wells Fargo & Company dropped their price objective on Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a report on Monday, May 18th. Zacks Research downgraded shares of Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 12th. The Goldman Sachs Group reaffirmed a “sell” rating and issued a $83.00 price target on shares of Clorox in a report on Friday, May 1st. Morgan Stanley reduced their price objective on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research note on Friday, May 1st. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a report on Friday, July 10th. One investment analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Reduce” and a consensus target price of $103.47.

Clorox Stock Performance

Shares of CLX stock opened at $96.13 on Thursday. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The company’s fifty day moving average price is $94.59 and its two-hundred day moving average price is $104.01. The firm has a market capitalization of $11.62 billion, a P/E ratio of 15.61, a P/E/G ratio of 0.46 and a beta of 0.54. Clorox has a 12 month low of $84.70 and a 12 month high of $132.03.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same period last year, the firm earned $1.45 earnings per share. The company’s revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, research analysts anticipate that Clorox will post 5.52 earnings per share for the current fiscal year.

Insider Activity at Clorox

In other news, Director Pierre R. Breber purchased 5,000 shares of the stock in a transaction dated Tuesday, May 5th. The stock was acquired at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the acquisition, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.63% of the company’s stock.

Hedge Funds Weigh In On Clorox

A number of hedge funds have recently added to or reduced their stakes in CLX. Caitlin John LLC lifted its position in shares of Clorox by 1,807.1% in the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after buying an additional 253 shares during the last quarter. Darwin Wealth Management LLC bought a new stake in shares of Clorox during the 2nd quarter valued at about $29,000. Vision Financial Markets LLC raised its stake in Clorox by 166.7% during the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after acquiring an additional 200 shares during the period. Root Financial Partners LLC lifted its holdings in Clorox by 83.8% in the first quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock worth $33,000 after acquiring an additional 145 shares during the last quarter. Finally, SHP Wealth Management acquired a new position in Clorox in the fourth quarter valued at approximately $35,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.